News

Find News

Filter articles

Showing 1 to 10 of 2172 results

Australia approves Arrow and Apotex merger

Australia21-09-2018

The Australian Competition & Consumer Commission announced yesterday that it has approved the merger of generic drugs companies Arrow and Apotex.

Gilead HIV drug not entitled to SPC, says UK court

UK20-09-2018

The English High Court has ruled that Gilead’s drug Truvada is not entitled to a supplementary protection certificate because it failed to meet the standards set out by Europe’s highest court earlier this year.

ERS extends CRISPR influence with two licensing deals

US20-09-2018

ERS Genomics and the Broad Institute of MIT and Harvard signed CRISPR licensing deals with Thermo Fisher Scientific on Tuesday, shortly before ERS expanded a separate agreement with Oxford Genetics.

CRISPR Therapeutics unites with ViaCyte to treat diabetes

Switzerland, US19-09-2018

Gene-editing company CRISPR Therapeutics has partnered with regenerative medicine-focused ViaCyte to focus on diabetes treatments.

Cancer Research UK invests £14m in biotherapeutics hub

UK19-09-2018

Researchers from three London universities and the Francis Crick Institute have joined together to form a hub for cancer biotherapeutics research and treatment, made possible by a £14 million investment from charity Cancer Research UK.

Federal Circuit overturns PTAB decision, hands victory to DuPont

US18-09-2018

The US Court of Appeals for the Federal Circuit yesterday overturned a Patent Trial and Appeal Board decision that had said chemical company DuPont hadn’t proved that a patent was invalid.

Allergan to acquire medical aesthetics company for $195m

Ireland, US18-09-2018

Allergan has revealed plans to buy Bonti, a biotechnology company focused on medical aesthetics, for $195 million.  

Second scientist pleads guilty to stealing GSK trade secrets

US17-09-2018

A former GSK scientist has pleaded guilty to charges that he conspired to steal trade secrets to benefit a China-based company that he helped establish, according to the US Department of Justice.

MSF critical of EPO decision to uphold Gilead’s hepatitis C patent

EU17-09-2018

The European Patent Office has upheld a patent covering Gilead’s hepatitis C medicine sofosbuvir, despite opposition from humanitarian organisation Médecins Sans Frontières.

J&J to acquire maker of 3D-printed spinal implants

Germany14-09-2018

Johnson & Johnson announced this week that its subsidiary J&J Medical has acquired Emerging Implant Technologies (EIT) for an undisclosed amount.

Showing 1 to 10 of 2172 results

LSIPR